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Abstract Cardiac ryanodine receptor (RyR2) is a homotetramer of 560 kDa polypeptides
regulated by calmodulin (CaM), which decreases its open probability at diastolic and systolic Ca2+
concentrations. Point mutations in the CaM-binding domain of RyR2 (W3587A/L3591D/F3603A,
RyR2ADA) in mice result in severe cardiac hypertrophy, poor left ventricle contraction and death
by postnatal day 16, suggesting that CaM inhibition of RyR2 is required for normal cardiac
function. Here, we report on Ca2+ signalling properties of enzymatically isolated, Fluo-4 dialysed
whole cell clamped cardiac myocytes from 10–15-day-old wild-type (WT) and homozygous
Ryr2ADA/ADA mice. Spontaneously occurring Ca2+ spark frequency, measured at −80 mV, was
14-fold lower in mutant compared to WT myocytes. ICa, though significantly smaller in mutant
myocytes, triggered Ca2+ transients that were of comparable size to those of WT myocytes, but
with slower activation and decay kinetics. Caffeine-triggered Ca2+ transients were about three
times larger in mutant myocytes, generating three- to four-fold bigger Na+-Ca2+ exchanger NCX
currents (INCX). Mutant myocytes often exhibited Ca2+ transients of variable size and duration
that were accompanied by similarly alternating and slowly activating INCX. The data suggest that
RyR2ADA mutation produces significant reduction in ICa density and ICa-triggered Ca2+ release
gain, longer but infrequently occurring Ca2+ sparks, larger sarcoplasmic reticulum Ca2+ loads, and
spontaneous Ca2+ releases accompanied by activation of large and potentially arrhythmogenic
inward INCX.
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Introduction
Excitation–contraction coupling in cardiac muscle is
initiated by activation of voltage-gated Ca2+ channel
and influx of Ca2+ that in turn triggers Ca2+ release
from the ryanodine receptors (RyR2) of the sarcoplasmic
reticulum (SR). The regulation of Ca2+ release from
RyR2 is mediated not only by influx of Ca2+, but
also by the host of regulatory proteins bound to
cytoplasmic domains of RyR2s that include calmodulin
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(CaM), protein kinase A (PKA), FK506-binding protein
(FKBP12.6), CaM-dependent protein kinase (CaMKII),
protein phosphatases (calcineurin), and junctional and
luminal SR proteins junctin, triadin and calsequestrin
(Franzini-Armstrong & Protasi, 1997; Lanner et al. 2010).
CaM is a small cytoplasmic Ca2+ binding protein, which
regulates the RyR2s either by its direct binding to
RyR2 or indirectly by regulating other proteins, CaMKII
and CaM-stimulated protein phosphatase (calcineurin)
(Balshaw et al. 2002; Saimi & Kung, 2002; Maier & Bers,
2007). In addition, RyR2 seems also to be regulated by
cytosolic Ca2+, Mg2+ and ATP (Meissner, 1994; Fill &
Copello, 2002). The regulation of Ca2+ signalling by CaM
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becomes somewhat more intricate as CaM also regulates
two other proteins of the Ca2+ release and uptake pathway,
namely the voltage-activated Ca2+ channel (Cav 1.2) of the
surface membrane (Anderson et al. 1994; Tang et al. 2002),
and Ca2+-ATPase (SERCA2a) of the SR (Simmerman &
Jones, 1998).
It has been already reported that CaM decreases the
open probability of RyR2 and that deletion of amino acid
residues 3583–3603 of RyR2 eliminates CaM binding and
its regulation (Yamaguchi et al. 2003). To explore the
role of CaM regulation of RyR2 in vivo, a mouse model
was generated that expressed RyR2s with three amino
acid replacements (RyR2-W3587A/L3591D/F3603A,
RyR2ADA) that impaired CaM regulation in vivo
(Yamaguchi et al. 2007). The homozygous expression
of RyR2ADA in mice resulted in larger hearts, severe
cardiac hypertrophy, impaired left ventricle contraction
and significant bradycardia (461 ± 19 vs. 598 ± 21
beats per minute), leading to death by postnatal day
16 (Yamaguchi et al. 2007). Cardiac hypertrophy and
impaired left ventricle contraction were prominent in
Ryr2ADA/ADA mice at postnatal day 1, and gene remodelling
associated with cardiac hypertrophy was observed at
embryonic day 16.5. The results suggest a significant
role for CaM regulation of RyR2 in early development
of the heart (Yamaguchi et al. 2007, 2011). In single
channel recordings of RyR2, at high Ca2+ concentrations,
exogenous application of CaM (1 μM) to the cis side of
the bilayers, while reducing RyR2 open probability of
wild-type (WT) had little or no effect on the mutant
RyR2 (Yamaguchi et al. 2007).
In this study, the locus and extent of Ca2+ signalling
defect affected by this mutation were explored in
voltage-clamped myocytes to determine whether impaired
Ca2+ signalling was responsible for cardiac failure and
early death of the homozygous mice.
Methods
Mice
RyR2ADA mice were generated and established as described
previously (Yamaguchi et al. 2007). Heterozygous mice
(Ryr2+/ADA) were at least 10 times backcrossed to 129/svev
genetic background and were used for breeding to obtain
WT and homozygous (Ryr2ADA/ADA) mice. As homozygous
mice die within 2–3 weeks, we used 10–15-day-old mice in
the present study. All protocols were approved by Medical
University of South Carolina Institutional Animal Care
and Use Committees.
Cell isolation procedure
Single cardiomyocytes were prepared by enzymatic
dissociation using modification of previously published
methods (Mitra & Morad, 1985). Mice were injected
with heparin (500 IU, I.P.) and anaesthetized with iso-
flurane. After sedation, the heart was excised and placed
in a dish filled with 2 mM Ca2+ Tyrode’s solution at
ambient temperature containing (in mM): 10 Hepes, 0.33
Na2HPO4, 110 NaCl, 1 MgCl2, 30 taurine, 15.4 L-glutamic
acid and 10 glucose. Hearts were cannulated above the
aortic valve and infused with Tyrode’s solution with 2 mM
Ca2+ for 1 min (3 ml min−1) to clean blood from the tissue
and then transferred to a Langendorf flow system. Hearts
were perfused on the Langendorf apparatus for 6 min
with Ca2+-free Tyrode (37◦C, pH 7.4, at 2 ml min−1 for
controls, 3 ml min−1 for Ryr2ADA/ADA mice) containing
10 μM Blebbistatin. Subsequently, hearts were digested
by perfusing collagense II (657 U ml−1, Worthington,
Lakewood, NJ, USA, lot 49H11299) and 2.5% trypsin
(0.3 mg ml−1) enzymes dissolved in Tyrode’s solution
(containing 12.5 μM CaCl2 and 10 μM Blebbistatin) for
7–10 min until the tissue became soft to the touch or a
sudden increase in flow rate occurred indicating effective
tissue digestion. To halt enzymatic digestion, hearts
were then perfused for 5 min with Ca2+-free Tyrode’s
solution containing 10% foetal bovine serum and 10 μM
Blebbistatin. Once enzymes were effectively washed from
the tissue, the ventricles were cut into large pieces and
placed in a 15 ml conical tube containing 2.5 ml of same
solution and placed in a 37◦C water bath. To avoid Ca2+
overload, Ca2+ was slowly reintroduced to the cells in a
step-wise fashion. Every 4 min, the contents of the tube
was gently mixed by inversion and CaCl2 was added to the
cells to increase the concentration from 12.5 μM to 62 μM,
112 μM, 212 μM, 500 μM and finally 1 mM. At this point,
cells were allowed to settle by gravity for 10 min in the bath
and then the pellet was re-suspended in 10 ml Tyrode with
1 mM Ca2+ and filtered to obtain single cells with a 70 μm
filter (BD Biosciences, San Jose, CA, USA, Ref 354232).
The filtered single cells were then plated on laminin-coated
(10 μg ml−1) glass coverslips and were allowed to recover
and adhere fully for at least 2 h before their use in electro-
physiological and imaging experiments.
Whole cell recordings of membrane currents
Membrane currents were measured in the whole cell
configuration of the patch clamp technique (Hamill et al.
1981) using a DAGAN 8900 amplifier (Dagan Corp.,
Minneapolis, MN, USA) and data were acquired through
the Digidata 1320A digitizer board (Axon Instruments,
Foster City, CA, USA) with a sampling frequency of
10 kHz. The measured series resistance was approximately
three times the pipette resistance and was electronically
compensated through the amplifier. Patch electrodes were
fabricated from borosilicate capillary glass with filament
(1B150F-4; World Precision Instruments, Sarasota, FL,
USA) and pulled using a Brown Flaming type pipette
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puller (model P-87; Sutter Company, Novato, CA, USA)
to a tip resistance of 3–7 M when filled with a Cs+-based
internal solution. This solution contained (in mM): 127
CsCl, 5 tetraethylammonium chloride, 5 NaCl, 10 Hepes,
5 MgATP, 5 glucose with different additions of Ca2+ and
Ca2+ probes suitable for whole cell Ca2+ measurements
or confocal Ca2+ imaging. pH was titrated to 7.2 with
CsOH. The standard external solution was composed
of (in mM): 137 NaCl, 5.4 KCl, 1 MgCl2, 10 Hepes, 2
CaCl2, 2 glucose and titrated to pH 7.4 with NaOH.
Ag-Cl ground and inner pipette electrodes were used and
seal resistance before patch rupture ranged from 2 to
10 G. A multibarrelled perfusion system (Cleemann &
Morad, 1991) was used for application of K+-free external
solutions during recording of membrane currents and
for rapid (∼50 ms) application of caffeine (10 mM). The
generation of voltage clamp protocols and data acquisition
was controlled by pCLAMP software (version 10.2; Axon
Instruments, Inc.). Three clamp pulse protocols were
used: (1) holding the membrane potential at −80 mV
while caffeine-induced Ca2+ transients and the associated
membrane current (INCX) were measured; (2) pulse
protocols of various magnitudes and durations were
applied from holding potentials of −80 or −60 mV
to activate Ca2+ currents (ICa); and (3) Ca2+ sparks
or spontaneous Ca2+ waves were monitored at rapid
imaging frame rates at holding potentials of −80 mV. The
pCLAMP software provided automated measurements of
membrane capacitance using 10 mV test pulses from a
holding potential of −60 mV. The accurate detection of
INCX was facilitated by choosing cells with little or no leak
currents and by suppression of K+ currents by the use
of a K+-free external solution and a Cs+-based internal
solution with added tetraethylammonium. Furthermore,
the leak currents were not digitally subtracted by the P/N
method to avoid suppression of maintained components
of INCX. All the experiments were performed at room
temperature (∼25◦C).
Global intracellular Ca2+ measurements
Intracellular Ca2+ activity was measured according to
previous methods (Cleemann & Morad, 1991) using
a dialysing pipette solution with addition of 0.5 mM
CaCl2 and 0.5 mM of the fluorescent Ca2+-indicator dye
K5Fura-2. Briefly, ultraviolet light originated from a
100 W mercury arc lamp, was split into two beams by
a mirror vibrating at 1200 Hz for high time resolution
and alternately passed through excitation filters above and
below the isosbestic point (380/14 and 340/20 nm) before
they were recombined to allow ratiometric detection of
Ca2+. The parameter, F , plotted in these experiments
(Figs 3–6 and 8) is the ratio of two signals obtained
with excitation at wavelengths where Ca2+ respectively
increases and decreases the intensity of fluorescent light.
To enhance sensitivity, background fluorescence from the
pipette solution was eliminated by removing the patch
pipette from the field of view of the detector with an
adjustable iris.
Two-dimensional confocal imaging
The time course of local Ca2+ signals was measured
in voltage-clamped cardiomyocytes with Fluo-4 using a
Noran Odyssey XL rapid two-dimensional laser scanning
confocal microscopy system (Noran Instruments,
Madison, WI, USA) attached to a Zeiss Axiovert TV135
inverted microscope fitted with an ×63 water-immersion
objective lens. In these experiments, the dialysing solutions
contained additions of either: (1) 1 mM EGTA, 1 mM
K5Fluo-4 and 0.6 mM CaCl2, or (2) 0.5 mM K5Fluo-4 and
0.2 mM CaCl2. The excitation wavelength of the argon ion
laser was set to 488 nm, and fluorescence emission was
measured at wavelengths > 515 nm. Cells were imaged
confocally at 30–120–240 frames s−1 depending on the
experimental requirement. To reduce photobleaching, the
laser beam used for excitation of Fluo-4 was electro-
nically shuttered and triggered to open on command
by the pClamp program only during acquisition of
data. The average resting fluorescence intensity (F0) was
calculated from several frames measured immediately
before voltage clamp depolarization or drug application or
from selected frames without indication of spontaneous
Ca2+ signals in the form of sparks or waves. Images were
filtered by 2 pixel × 2 pixel averaging. The amplitudes
of the Ca2+-dependent cellular fluorescence signals
were quantified as F/F0, where F is the change
in fluorescence. This type of normalization could be
applied both to the integrated signals from the entire cell
(Fig. 2AC) and to the generation of ratiometric images
where both F0 and F were measured locally (Figs 2B and
D and 7A and C).
Membrane structures were measured in live cells
with the Noran Odyssey XL confocal microscope
using the lipophilic potentiometric dye di-2 ANEPEQ
(Fig. 1C, bottom). For immunolabelling of proteins, the
isolated mouse cardiomyocytes were fixed with 100%
methanol for 10 min at 4◦C and were blocked with
1% bovine serum albumin and 0.1% Triton-X100 in
phosphate-buffered saline for 1 h at room temperature.
Primary and secondary antibodies for immunostaining
were C3–33 monoclonal antibody (Thermo, Waltham,
MA, USA) and fluorescein isothiocyanate-conjugated
antimouse IgG antibody (for RyR2) and π antibody
and Texas red conjugated antirabbit IgG antibody (for
NCX). The secondary fluorescent antibodies were from
Jackson ImmunoResearch (West Grove, PA, USA) and
were imaged on a Leica SP5 confocal microscope.
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Chemicals
Mg-ATP and caffeine were from Sigma (St. Louis, MO,
USA), and Fura-2 pentapotassium salt from Molecular
Probes (Eugene, OR, USA).
Data analysis and statistics
Analysis of ion current amplitude was made with the
CLAMPFIT module of pClamp 10.2 software. Data are
reported as means ± S.E. Comparisons were done using
Student’s unpaired t test with P values indicated in the
figures.
Results
Mutation of type 2 ryanodine receptor at the
calmodulin-binding site
It has been already reported that homozygote mice
carrying RyR2ADA mutation that causes reduced CaM
binding to RyR2s, develop significant cardiac hyper-
trophy at postnatal day 1 compared to WT mice, and
die within 2–3 weeks of birth (Yamaguchi et al. 2007,
2011). Functional evidence for ineffective CaM binding
is based on findings that 1 μM CaM failed to decrease the
mean open probability of RyR2ADA, when added to cis
(cytoplasmic) side of the bilayers containing the channel,
as it did when WT RyR2 was incorporated in to the
bilayers. Kinetic analysis revealed no significant differences
between CaM-depleted WT and mutant channels in the
number of channel events and mean open or closed times
(Yamaguchi et al. 2007). Figure 1A shows a schematic
representation of CaM-binding domain of RyR2 vis-à-vis
some of the other well known regulatory phosphorylation
and Ca2+ binding sites of this protein. Figure 1B compares
representative images of two hearts obtained from WT
and mutant mice at 11 days of life confirming massive
cardiac hypertrophy (Yamaguchi et al. 2007). Figure 1C
compares immunofluorescent distribution of RyR2, and
NCX proteins, as well as membrane staining with a
voltage-sensitive dye of three pairs of ventricular myo-
cytes from WT and mutant mice. While the membrane
staining (Mem) shows both the surface membrane and
the sarcomeric pattern of its t-tubular invaginations, it
is noticeable that NCX staining is most prominent in
the former and RyR2-staining confined to the latter.
Deformation of t-tubules is apparent in hypertrophied
myocytes from mutant mice (arrows), especially when
using the voltage-sensitive fluorescent dye. There was
also considerable non-uniformity in the extent of cellular
hypertrophy between myocytes. Compare for instance,
NCX immunostained myocyte pairs with RyR2-stained
pairs.
Figure 1. CaMBD of RyR2 (A) causes cardiac hypertrophy (B) and disorganized cellular structure (C)
A, location of the CaMBD in the context of binding domains for FKBP12.6 and Ca2+, phosphorylation sites and hot
spots for mutations causing catecholaminergic polymorphic ventricular tachycardia such as the F2431I mutation
(Li & Chen, 2001; Lanner et al. 2010; Fatima et al. 2011). B, hypertrophy of hearts from HOM as seen at day 11
compared to WT. C, distributions of RyR2, NCX and Mem staining with voltage-sensitive dye (di-ANEPQ) in freshly
isolated WT and HOM cardiomyocytes showing sarcomeric distributions with differing regularity and predominant
localization of NCX at the surface membrane. It is noticeable that the ultrastructure of HOM cells is much less
organized. Arrows in the right panel suggest that HOM cells have more prominent longitudinal tubules. Nuclei are
marked with Ns and/or blue staining (top). CaMBD, calmodulin-binding domain; HOM, homozygous mutant mice;
LA, left atria; LV, left ventricle; Mem, membrane; NCX, Na+-Ca2+ exchanger; RA, right atria; RV, right ventricle;
RyR2, type 2 ryanodine receptor; WT, wild-type.
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ICa- and caffeine-induced Ca2+ release in mutant vs.
wild-type mice
Cardiomyocytes from the WT and mutant mice were
voltage clamped from holding potentials of −40 or
−60 mV to avoid activation of residual INa, using step
pulses to zero mV. Whole cell ICa and the accompanying
Ca2+ transients activated by depolarizing pulses of
200–400 ms to 0 mV (Fig. 2A and B) were compared
to those triggered by 2 s puffs of 5–10 mM of caffeine
(Fig. 2C and D). Note that both the average rise in
global cytosolic Ca2+ (Fig. 2A and C) and confocal images
of Ca2+ distributions measured at 30 Hz (Fig. 2B and
Figure 2. Ca2+ transients and membrane currents in single
voltage-clamped cardiomyocytes from WT (black traces) and
HOM (grey traces) mice
A, calcium transients (Fluo-4, F/F0, bottom) evoked by activation of
ICa (top) during 400 ms depolarizations to 0 mV. B, ratiometric
confocal images (F(x,y,t)/F0(x,y)) of Fluo-4 fluorescence measured
at 30 Hz at the onset of the depolarization. The first frame in each
sequence was recorded just before depolarization and shows a fairly
uniform coloration over the entire cell with some blue/green mottle
corresponding to the noise of the recordings. In the next frame, the
WT cell shows an abrupt increase in fluorescence as a transition to
warmer colours (See colour scale) yellow, half way through the
30 ms scan from top to bottom. In comparison, the second frame
from the cardiomyocyte from the HOM mouse shows a delayed and
gradual increase in fluorescence that starts at the edges, increases
slowly towards the end of the scan and is still rising in the following
two frames. C, INCX (top) and Ca2+ transients evoked by a 2 s
application of 10 mM caffeine. D, ratiometric confocal fluorescence
images indicate that Ca2+ signals evoked by caffeine start at the
ends of the cells and rise more slowly than those triggered by ICa,
especially in cells from the HOM mouse. E, ratio of the Ca2+ releases
was calculated as the magnitude of depolarization-induced Ca2+
transients compared to those evoked by caffeine. This efficiency of
ICa-gated Ca2+ release (fractional release) was significantly larger for
WT (82%) than for HOM (30%) mice. The cells were dialysed with
an internal solution containing 0.5 mM K5Fluo-4 and 0.2 mM CaCl2.
HOM, homozygous mutant mice; WT, wild-type.
D) suggest a slower rise in cytosolic Ca2+ in mutant as
compared to WT myocytes (Fig. 3). Interestingly, although
the slower kinetics of Ca2+ release were also apparent in
mutant myocytes in caffeine-triggered images of release
of SR Ca2+ stores (compare confocal caffeine images,
Fig. 2D), caffeine-triggered Ca2+ release was significantly
larger and more sustained in mutant myocytes, and was
accompanied by much larger INCX (Fig. 2C, see also
Fig. 6C and D). Comparing the ratio of ICa-triggered
Ca2+ release to the magnitude of caffeine-triggered Ca2+
release in mutant and WT myocytes (Fig. 2E) suggests
that the efficiency of ICa to trigger Ca2+ release from
the SR stores was significantly compromised in mutant
myocyte, such that only about 30% of the stored Ca2+
is released in mutants compared to about 80% in WT
myocytes.
Voltage dependence of ICa-triggered Ca2+ release
Figure 3 compares sample records and the voltage
dependencies of ICa and the ICa-triggered Ca2+ trans-
ients in control and mutant myocytes, showing similar
bell-shaped voltage dependence for ICa and Ca2+ trans-
ients. There was, however, a clear difference in rate of
activation of Ca2+ transients, such that they developed
slower in mutant homozygote myocytes (Fig. 4). Although
there was significant variability in the rate of relaxation
of Ca2+ transients in mutant mice, there was a general
tendency toward slower rates of relaxation in mutant myo-
cytes, most likely related to the variability in the pathology
of individual myocytes.
There was significant variability not only in Ca2+ trans-
ient kinetics between myocytes, but also in cell capacitance
and ICa of both mutant and WT myocytes. Figure 5
compares the density of ICa in 37 WT and 52 mutant myo-
cytes. ICa was significantly larger in WT (12–14-day-old
mice) myocytes, about 12 pA/pF, compared to 6 pA/pF in
mutant myocytes. Interestingly the smaller ICa (Fig. 6C)
did not produce smaller ICa-triggered Ca2+ transients in
mutant mice (Fig. 6A). This surprising finding may be, in
part, related to the larger Ca2+ load of SR in mutant mice
as indicated by three to four times larger caffeine-triggered
Ca2+ transients, generating also the much larger INCX (Fig.
6B and D).
Figure 6E compares the gain of the ICa-triggered Ca2+
release (CICR) mechanism (i.e. the ability of ICa to
release Ca2+ when corrected for the SR Ca2+ content)
in the two sets of myocytes. We confirmed, as previously
reported by a number of investigators, that the gain of
CICR is significantly higher at −30 mV compared to
0 mV (Adachi-Akahane et al. 1996) in WT myocytes. In
mutant myocytes, the gain was significantly smaller at both
voltages, but the voltage dependence of gain of CICR was
maintained.
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
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Calcium sparks: kinetics, size and frequency
To gain more insight into the unitary activity of RyR2 in
intact or patch-clamped myocytes from mutant mice, we
compared the kinetics, frequency and the size of triggered
or spontaneously occurring Ca2+ sparks with those of WT
myocytes using a two-dimensional rapid confocal imaging
system (Cleemann et al. 1998). Figure 7A and B shows
that the frequency of spontaneously occurring sparks was
significantly lower in mutant myocytes. This was especially
unexpected as the Ca2+ load of SR was significantly larger
in mutant myocytes (Fig. 6B). The number of sparks
decreased from an average of 4 s−1 in control myocytes
to 0.25 s−1 in mutant myocytes (Fig. 7B). Nevertheless,
the rarely occurring spontaneous sparks in mutant mice
were slow to develop and were of longer durations, lasting
often for 250 ms (Fig. 7E and F). No significant difference
was found in the amplitude of sparks in the two sets of
myocytes (Fig. 7D).
Phosphorylation of Ca2+ signalling pathways
As a number of RyR2 mutations make this protein
susceptible to irregular activity (George et al. 2007;
Fig. 1), we tested whether RyR2ADA mutation altered the
adrenergic regulation of ICa and ICa-triggered Ca2+ trans-
ients such as to increase the susceptibility of mutant mice
to arrhythmogenesis and early death within 3 weeks of
birth. We found that isoproterenol plus phosphodiesterase
inhibitor IBMX significantly increased ICa and Ca2+ trans-
ients in a set of five mutant and control myocytes. There
appeared to be no difference in qualitative or quantitative
effects of isoproterenol between the two sets of myocytes
(data not shown).
Figure 4. Average values of the rate of rise and decay of
Fura-2-detected cytosolic Ca2+ transients measured during
400 ms depolarizations from −50 to 0 mV
A, rate of rise (F/ms) was significantly slower in HOM than in the
WT mice (P < 0.01). B, rate of decay showed considerable variation
in the HOM mice, but on average was not significantly different
from the WT. Ca2+-sensitive fluorescence was measured using Fura2
dialysed cells (0.5 mM Fura2 and 0.5 mM Ca2+. HOM, homozygous
mutant mice; WT, wild-type.
Figure 3. Voltage dependence of ICa and
ICa-activated Ca2+ transients in
cardiomyocytes from WT (A and C) and
HOM (B and D)
A and B, representative traces where ICa was
normalized relative to the membrane
capacitance and changes in the Ca2+-dependent
fluorescence (F/F0) was measured
ratiometrically with Fura-2. The recordings were
obtained with 200 ms depolarizing pulses from a
holding potential of −50 mV in 10 mV steps to
+70 mV. C and D, voltage dependencies of peak
ICa and F/F0. The internal solution contained
5 mM Na+, and was Ca2+ buffered with 0.5 mM
Fura-2, and 0.5 mM Ca2+. HOM, homozygous
mutant mice; WT, wild-type.
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Alternans and activation of large Na+-Ca2+
exchanger currents
It was a common finding that in a population of mutant,
but never in WT myocytes, the Ca2+ release signal
alternated between larger and smaller Ca2+ transients
(Fig. 8A). The larger signal had two components, a rapid
component triggered by ICa and a slower component
that occurred spontaneously at variable times following
the fast release of Ca2+ (Fig. 8A–E) and was always
accompanied by large activation of INCX. Activation
of the PKA–phosphorylation pathway often increased
the proclivity for the occurrence of secondary Ca2+
releases and accompanying INCX, but there was significant
inter-myocyte variability in occurrence of these large
secondary Ca2+ release events to make the difference
statistically insignificant (Fig. 8F and G).
Discussion
The major findings of this report are that genetically
modified mice carrying RyR2ADA mutations express major
Ca2+ signalling aberrancies in their freshly isolated hyper-
trophied ventricular cells that include: lower expression
of ICa density and CICR gain; long-lasting but infrequent
Ca2+ sparks; and slowly developing global Ca2+ transients
despite the larger Ca2+ load of the SR.
Variability in myocyte size and Ca2+ signalling
There was significant variability in myocyte size and
density of ICa, but on average the cell size (membrane
capacitance) was larger and ICa smaller in the mutant
than in control myocytes (Figs 1C, 2B, D and 5D). The
myocytes’ current and size variability, does not appear to
reflect progression of cardiac pathology in the mutant
mice as it was also present in the WT mice and may
be, in part, related to the young age (10–15 days) of
the mice, as previously reported in neonatal myocytes
(Yan et al. 2011). Interestingly this variability did not
extend to the size of caffeine-triggered Ca2+ stores. It was
a hallmark of mutant myocytes that caffeine-triggered
transients were consistently three to four times larger
than the ICa-triggered Ca2+ transients producing markedly
larger INCX of about 3–4 pA/pF compared to 0.8–1.0 pA/pF
in WT myocytes (Fig. 6B and D). Although the pre-
sence of more disorganized structures and prominent
longitudinal t-tubules in homozygous cardiomyocytes
may reflect the greater fragility of mutant myocytes, it
should be noted that these features were also observed
not only in fixed and immunostained cells (Fig. 1C,
RyR and NCX), but also in enzymatically dissociated
live cells where membrane structures were visualized with
di-2-ANEPEQ (Fig. 1C, Mem). To prevent experimental
bias, most of Ca2+ signalling experiments were carried
Figure 5. Distribution of calcium currents (ICa) density and average cell capacitance (Cm) in WT and
HOM mice
ICa was recorded from a holding potential −50 mV with step depolarization to 0 mV. A and B, distribution of ICa
densities in 37 cardiomyocytes from seven WT mice (A) compared to those in 52 cardiomyocytes from eight HOM
mice (B). C, average ICa density was larger in WT than in HOM mice. D, average membrane capacitance of the
cardiomyocytes was 60 ± 6 pF in WT myocytes compared to 92 ± 8 pF in the HOM myocytes. S.E.M. and thereby
P values, in C and D are based conservatively on the numbers of experimental animals (seven and eight). HOM,
homozygous mutant mice; WT, wild-type.
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Figure 6. Average values of ICa, INCX, Cai
transients (Fura-2 signals), and gain factor
in WT and HOM mice myocytes
A and C, average Ca2+ signals (A) evoked ICa
at 0 mV (C) in each group. B and D, average
values of caffeine-activated Ca2+ signals (B)
and the accompanying INCX (D) in each group.
E, average valves of gain factor at −30 and
0 mV. The gain factor is plotted in units
corresponding to the fraction (in %) of the
caffeine-induced Ca2+ release, which is
released by an ICa with a density of 1 pA/pF
(WT black, HOM grey). Ca2+ transients were
measured with Fura-2. HOM, homozygous
mutant mice; WT, wild-type.
Figure 7. Calcium sparks in Fluo-4-dialysed voltage-clamped cardiomyocytes from WT and HOM mice
A, ratiometric recording of Ca2+ sparks in whole cells at 30 Hz. From top to bottom each panel shows: (1)
images of the average fluorescence distributions in frames without Ca2+ sparks (F0(x,y)); (2) colour-coded regions
of interests corresponding to locations of Ca2+ sparks (middle panel); (3) examples of sparks as seen in single
normalized frames (F(x,y)/F0(x,y)), lower panel; and (4) the time course of the normalized fluorescence intensity
at the chosen locations. B, number of sparks per cell per second was reduced from 3.62 ± 0.54per s in WT to
0.26 ± 0.17 per s in HOM cells. C, time course of Ca2+ sparks measured at 240 frames per s in portions of cells.
At the top are shown colour-coded locations of Ca2+ sparks and sample frames with sparks at these locations.
The traces below show the time course of F/F0 in colour-coded traces corresponding to the chosen locations.
For illustration purposes, we chose a rare mutant cell with several sparks that nevertheless was characteristic in
having long durations. D and E, amplitude of the Ca2+ sparks are comparable in WT and HOM, but the duration is
significantly longer in the HOM (FWHA). F, distribution of the sparks in the WT and the HOM according to F/F0
and FWHA. FWHA, full width at half amplitude; HOM, homozygous mutant mice; WT, wild-type.
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out blind, i.e. the mouse genotype was hidden from the
experimenter.
Ca2+ signalling parameters: sparks, gain and
store size
The most striking Ca2+ signalling phenotype of the
freshly isolated mutant mice myocytes was that they had
prolonged, but infrequent Ca2+ sparks, slowly developing
and decaying Ca2+ transients and larger caffeine-triggered
stores. The Ca2+ signalling profile of Ryr2ADA mutant
mouse heart has been summarized in Table 1. As pre-
vious measurements of [3H]-ryanodine binding and
single channel parameters showed significant differences
between control and mutant RyR2 only in the presence of
CaM (Yamaguchi et al. 2007), it is unlikely that other major
‘unspecific’ alterations in the channel conformation are
induced by the mutation. This implies that the observed
changes in Ca2+ signalling parameters are associated either
directly with the loss of CaM-dependent inhibition of
Figure 8. Spontaneous Ca2+ releases and associated INCX in cardiomyocytes from homozygous mutant
mice
From top to bottom each panel shows voltage clamp depolarizations, membrane currents and cellular Ca2+ signals
measured ratio metrically with Fura-2. A, six consecutive depolarizations at 0.2 Hz with alternating spontaneous
large Ca2+ releases and INCX. B–E, cells with spontaneous Ca2+ releases and INCX with variable magnitudes and
delays. F and G, cumulative effects of repeated depolarizations leading to large delayed Ca2+ releases before (F)
and after (G) exposure to forskolin.
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
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Table 1. Structural and functional changes in cardiomyocytes from homozygous mice expressing RyR2ADA
Wild-type → Mutant  Change
Cell surface area, membrane capacitance 60 → 90 (pF) ↑
t-tubular structure Disrupted ↓
ICa density 12 → 6 (pA/pF) ↓↓
ICa-triggered Ca2+ release gain −30 mV ↓
0 mV ↓↓
ICa-activated Cai transients Amplitude ←→
Kinetics ↓↓
Ca2+ load of sarcoplasmic reticulum ↑↑↑
SERCA 2A (uptake rate) 60% decrease ↓↓
Caffeine-triggered INCX 1 → 5 (pA/pF) ↑↑↑
Frequency of spontaneous Ca2+ releases ↑↑
Fractional Ca2+ release 80% → 30% ↓↓
RyR2 [3H] ryanodine binding 70% decrease ↓↓↓
Ca2+ sparks Frequency 3.5 s−1 → 0.3 s−1 ↓↓↓
Duration 50 → 250 (ms) ↑↑
Amplitude ←→
RyR2, type 2 ryanodine receptor.
RyR2 or with secondary compensatory changes in cellular
structure and protein expression that in combination
produce this lethal pathology.
The low frequency of Ca2+ sparks in cells with mutant
RyR2s was surprising considering that the loss of CaM
inhibition might be expected to increase the triggering
of spontaneous Ca2+ releases. The lower spark frequency
may result from a lower number of RyR2s, expressed
in disorganized clusters (Yamaguchi et al. 2007) and
by taking into account that CaM inhibition of channel
activity is of little importance at the diastolic Ca2+
concentration that precede the formation of Ca2+ sparks.
The long duration of the Ca2+ sparks in mutant cells
(Fig. 7E), on the other hand, results most likely from the
increased SR Ca2+ load and suppressed CaM-dependent
inhibition (causing increased channel open probability;
Yamaguchi et al. 2007), which comes into play only after
a triggered Ca2+ spark causes an increase in the local
Ca2+ concentration. The long duration of Ca2+ sparks
is also consistent with the longer durations of Ca2+ trans-
ients reported in cultured homozygous neonatal cardio-
myocytes (Yamaguchi et al. 2007) and with the idea that
CaM binding to RyR2 regulates the termination of SR Ca2+
release (Xu & Meissner, 2004; Yamaguchi et al. 2007). The
tendency for slower rates of decay of Ca2+ transients in
mutant myocytes, but with larger S.E.M. (Fig. 4B), most
likely arises from the possibility that the longer durations
sparks may reactivate the couplons where dihydropyridine
receptors and RyR2s are uncoupled because of cellular
hypertrophy and t-tubular deformations. The degree to
which such couplons are activated in time and space are
likely to be responsible for slowly decaying Ca2+ transients
(e.g. Fig. 8B), and possibly secondary releases of Ca2+
(Fig. 8C–E). It should be emphasized that the earlier
reported measurements of Ca2+ signalling (Yamaguchi
et al. 2007) were carried out on cultured myocytes
where major changes in the t-tubular expression are
known to occur that could have significant Ca2+
signalling consequences, especially when dealing with
mutations causing myocyte hypertrophy. In summary,
longer duration of Ca2+ sparks, one of the key findings
in the present study using freshly isolated myocytes,
is in good agreement with results from cultured myo-
cytes (Yamaguchi et al. 2007) and the finding that spark
frequency was significantly lower in mutant myocytes
could be related to the lower expression of RyR2s,
as indicated by ∼70% lower functional RyR2 proteins
([3H]-ryanodine binding) and ∼30% decrease of mRNA
in 10-day-old mice (Yamaguchi et al. 2007, see also Fig. 1C,
RyR2 panels), or the deformities in t-tubules SR junctional
membranes.
Although it is tempting to speculate that this lower
spontaneous spark frequency was also responsible for the
higher Ca2+ content of SR as suggested by the larger
caffeine-triggered Ca2+ releases (Figs 2C and 6B), this
possibility would be somewhat surprising considering
the lower activity of Ca2+-ATPase (SERCA2a/PLB) in the
mutant mice (Yamaguchi et al. 2007). Closer examination
of the Ca2+ release kinetics in mutant mice myocytes
suggests often the presence of two components to Ca2+
release; the larger and slower of which follows the rapid
and smaller ICa-triggered component of Ca2+ transients
(Fig. 8A), suggesting possibly sites of release somewhat
distal to the ICa-gated Ca2+ release. This finding could
be related, in part, to uncoupled RyR2s that due to myo-
cyte hypertrophy might have been dislocated from their
t-tubular dyadic junctions and therefore from their direct
gating by dihydropyridine receptors (Fig. 1C).
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Pathophysiology of RyR2ADA mutation
Decreased CaM binding to RyR2 appears to be lethal to
homozygote mice within the first 3 weeks of life. The
impairment of cardiac function is already apparent in
the first day of life where cardiac fractional shortening
decreases from ∼50% in WT to ∼34% in homozygote
mutant mice. Heterozygote mice survive into adulthood
and appear to have little or no changes in fractional
shortening, hypertrophy or Ca2+ signalling defects, as
most of the tetrameric RyR2s carry at least one WT sub-
unit, which is sufficient for CaM regulation (Yamaguchi
et al. 2007). In considering the cause of early mortality
in these mice, it has been proposed that massive hyper-
trophy and heart failure is the most likely cause of death.
At day 1 of postnatal life, the left ventricular contra-
ctility is already reduced to ∼70% of WT and at day
10 it is down to ∼20% of WT hearts. Gene remodelling
associated with cardiac hypertrophy was also detected in
early embryonic day 16.5 hearts (Yamaguchi et al. 2007,
2011). In the present study, we suggest that, in addition
to heart failure, arrhythmia may also contribute to the
early death of the mutant mice. Considering the size of
the mice and their hearts at this early stage of life, it was
difficult to test directly their propensity for arrhythmia
by telemetric ECG measurements. If indeed ICa-triggered
release is followed by a secondary release of Ca2+, as it is
suggested by experiments in Fig 8, the large INCX generated
by such releases would be highly arrhythmogenic in intact
hearts in vivo, and could be responsible for the early death
of the animal. Interestingly, we did not note an increase
in proclivity to alternans or rhythm aberrancies when the
mutant myocytes were subjected to β-adrenergic pathway
agonists. Perhaps this is not surprising considering that
the site of mutation was far removed from PKA-mediated
phosphorylation sites.
The three- to four-fold increase in the caffeine-induced
Ca2+ transients and INCX, reported here in freshly
dissociated cardiomyocytes from homozygous mutant
mice (Figs 2B, 6C and D), is somewhat at odds with
the unchanged caffeine-induced Ca2+ transients pre-
viously reported in cultured neonatal homozygote cardio-
myocytes (Yamaguchi et al. 2007). Perhaps this apparent
discrepancy in the caffeine-induced Ca2+ transients is
linked not only to differences in the experimental approach
(cultured vs. freshly isolated cells), but also to dye
saturation in the dye-incubated cells.
The larger Ca2+ load of the SR in mutant myocytes may
also be responsible for the often-observed spontaneous
releases of Ca2+ and its accompanying large INCX that
followed ICa-triggered Ca2+ transients, which if occurring
in intact hearts might activate early and delayed after
depolarizations, leading possibly to lethal arrhythmia in
the first 3 weeks of postnatal life. If indeed the pathology of
RyR2ADA mice myocytes is linked to Ca2+ overload of the
SR, but not necessarily to changes in 3-D ultrastructure,
it is then possible that the cellular Ca2+ overload may also
affect mitochondria rendering them incapable of buffering
the large Ca2+ transients or contributing with a Ca2+
release of their own (Belmonte & Morad, 2008). Thus,
the large caffeine-triggered rises in global Ca2+ may not
be simply reflecting the true content of SR, but also that of
Ca2+-overloaded mitochondria. Such an idea is consistent
with data of mutant hearts showing ∼60% decrease in
SERCA2 Ca2+ uptake rates at day 10, more consistent with
smaller rather than a larger SR Ca2+ content.
Somewhat similar hypertrophy was also reported in
calsequestrin overexpressing mice (Jones et al. 1998;
Knollmann et al. 2000) where the animals survived into
adulthood. It should be noted, however, that calsequestrin
overexpressing mice do not show heart failure in earlier
(<2 months) stages of development, while in sharp
contrast RyR2ADA hearts almost fail to have significant
contractions at postnatal day 10, suggestive of different
remodelling mechanisms. Indeed hypertrophy-induced
gene expression and remodelling in RyR2ADA mice start
in embryonic day 16.5, consistent with earlier cardiac
remodelling and hypertrophy.
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